Testing an AI Large Language Model Tool for Cognitive Debiasing in Musculoskeletal Care
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Jun 7, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether an artificial intelligence (AI) tool can help patients with chronic orthopedic conditions, like arthritis or carpal tunnel syndrome, better understand their symptoms and improve their visit with a specialist. The trial will compare two groups of patients: one group will use an AI-guided checklist to reflect on their thoughts about their symptoms, while the other group will receive a likely diagnosis based on their symptoms. Both groups will share the AI-generated information with their clinician before their appointment.
To participate, you need to be an adult seeking care for a musculoskeletal issue, speak English, and have a specific level of concerns about your symptoms. During the trial, you will answer some questions, attend your regular appointment, and complete a short survey afterwards to share your experience. The goal is to see if the AI tool can make patients feel more confident and satisfied with their care. This study is not yet recruiting, but it aims to help improve patient care in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults (18+)
- • New or return patient seeking musculoskeletal specialty care at an Orthopedic outpatient clinic
- • Total combined score on the 6 feelings and thoughts items of \> 10\* (Appendix 3 of study protocol)
- • English-speaking
- • Pre-visit diagnosis of chronic, non-traumatic musculoskeletal condition (including, but not limited to: osteoarthritis, carpal tunnel syndrome, trigger digit, Dupuytren's, De Quervain's, lateral epicondylitis)
- Exclusion Criteria:
- • Any impairment preventing completion of surveys on a tablet
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Patients applied
Trial Officials
David Ring, MD, PhD
Study Director
Dell Medical School, University of Texas at Austin, TX, United States
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported